Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 3/20 | 0.53 |
| ▸ | GNAO1 | P09471 | 3/20 | 0.53 |
| ▸ | GNAI1 | P63096 | 3/20 | 0.53 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 2/20 | 0.45 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6102555 | 0.94 | HRH3 (0.54) | GNAI3GNAO1GNAI1HRH3MGLL | |
| SCHEMBL15408434 | 0.94 | HRH3 (0.54) | GNAI3GNAO1GNAI1HRH3MGLL | |
| SCHEMBL15212251 | 0.94 | GNAI3 (0.59) | GNAI3GNAO1GNAI1MGLLFAAH | |
| SCHEMBL15408002 | 0.92 | HRH3 (0.58) | GNAI3GNAO1GNAI1HRH3MGLL | |
| SCHEMBL15408001 | 0.92 | HRH3 (0.58) | GNAI3GNAO1GNAI1HRH3MGLL | |
| SCHEMBL11733912 | 0.89 | GNAI3 (0.53) | GNAI3GNAO1GNAI1MGLLFAAH | |
| SCHEMBL11740646 | 0.89 | GNAI3 (0.53) | GNAI3GNAO1GNAI1MGLLFAAH | |
| SCHEMBL11733904 | 0.89 | GNAI3 (0.53) | GNAI3GNAO1GNAI1MGLLFAAH | |
| SCHEMBL11740636 | 0.89 | GNAI3 (0.53) | GNAI3GNAO1GNAI1MGLLFAAH | |
| SCHEMBL7478832 | 0.85 | HRH3 (0.62) | GNAI3GNAO1GNAI1HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024145281-A1 | BIODEGRADABLE LIPIDS AND FORMULATIONS FOR INTRAMUSCULAR, IN VITRO, AND EX VIVO TRANSFECTION OF MRNA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-07-04 | — | — | WO | disclosed |